Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00417794 · ClinicalTrials.gov registry record · Phase 1
Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
A Phase 1 study, sponsored by University of Oklahoma.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT00417794 is a Phase 1 study that has completed, run by University of Oklahoma. The registered enrollment target is 38 participants.
The verdict
NCT00417794, a Phase 1 study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if atomoxetine hydrochloride improves inattention, hyperactivity, and impulsivity problems in children exposed to alcohol during birth.
Interventions
- DRUG Placebo
- DRUG Strattera
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2005-08 |
| Est. Completion | 2015-04-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00417794
The ClinicalTrials.gov registry entry for NCT00417794 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00417794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00417794 about?
NCT00417794 is a clinical study titled "Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD". The purpose of this study is to determine if atomoxetine hydrochloride improves inattention, hyperactivity, and impulsivity problems in children exposed to alcohol during birth.
What is the current status of trial NCT00417794?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2005-08. Estimated completion is 2015-04-22.
What interventions are being tested in trial NCT00417794?
The interventions under investigation include: Placebo (DRUG), Strattera (DRUG).
Who is sponsoring clinical trial NCT00417794?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.